![]() The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Syneron Candela is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. William Griffing, Chief Executive Officer of Syneron Candela North America, said, "Based on the strong early reception to PicoWay, we believe we are well positioned to drive adoption in Canada based on our unique PicoWay technology, strong Candela brand, and broad existing customer base." ![]() The Company sells its products in Canada through its direct North American sales organization. ![]() and other international markets during the fourth quarter 2014. The launch of PicoWay in Canada will begin during the second quarter 2015, building on the launch of the product in the U.S. The Health Canada clearance is for all tattoo colors: red, yellow and orange for the 532nm wavelength black, brown, green, blue and purple for the 1064nm wavelength. PicoWay is a dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes proprietary PicoWay Technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos of all colors. The Company also announced Health Canada clearance of the PicoWay picosecond laser for the treatment of pigmented lesions and tattoo removal. Since launching the product late last year, there has been strong interest in PicoWay and we expect the addition of the pigmented lesion indication will further enhance its attractiveness to customers." It is also indicative of our commitment to add new applications that leverage the PicoWay technology for other treatments. The expansion of PicoWay's FDA clearance to include pigmented lesions further enhances the utility of the system, allowing practitioners to offer this next-generation technology for more of their pigment-related procedures. The innovative PicoWay Technology™ is integrated into a proven, reliable Candela platform which offers high reliability, superior performance and low cost of ownership.Īmit Meridor, Chief Executive Officer of Syneron Medical, said, "PicoWay offers our customers a reliable and easy-to-use system featuring the shortest picosecond pulse and the highest peak power on the market. The high energy ultra-short picosecond laser pulse creates a strong photo-mechanical impact that optimizes fracturing of tattoo ink or pigmentation. PicoWay incorporates picosecond (one trillionth of a second) pulse duration to generate an ultra-short pulse and very high peak power of laser energy on the skin. The PicoWay picosecond laser previously received FDA clearance for the removal of tattoos in November 2014 and was launched in the U.S. Food and Drug Administration (FDA) clearance for the treatment of pigmented lesions. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that the PicoWay® picosecond laser received U.S. Yokne'am Israel /PRNewswire/ - Syneron Medical Ltd.
0 Comments
Leave a Reply. |